Pluvicto in greece?

Pluvicto is the brand name for lutetium Lu 177 vipivotide tetraxetan (a radioactive PSMA-targeted therapy for certain prostate cancers).

In Greece, Pluvicto is generally available through hospital/radiopharmaceutical supply pathways, but access depends on things like:
- whether the treatment is authorized/prescribed for the exact indication you have,
- hospital availability (nuclear medicine/radiopharmacy capability), and
- whether your oncology/urology center is set up to procure and administer it.

If you tell me a bit more, I can guide you to the most relevant next step:
1) Is this for metastatic castration-resistant prostate cancer (mCRPC) (often post-chemo), or another setting?
2) Which area/city in Greece are you near?
3) Are you asking about availability, how to get it, or pricing/coverage (insurance/ETEA/ΕΟΠΥΥ/private)?

In the meantime, the practical route is usually:
- Your oncologist refers you to a nuclear medicine/theranostics team at a major cancer center or hospital that administers Lu-177 PSMA therapy.
- The center coordinates procurement and treatment scheduling (including PSMA imaging confirmation and required labs).

Reply with the details above and I’ll tailor the guidance.